PHARMACEUTICAL COMPOSITION INTENDED FOR APPLICATION FOR PREVENTION AND / OR TREATMENT OF A DISEASE THAT IS DEVELOPING OR PROGRESSING AS A RESULT OF REDUCTION OR LOSS OF SURVIVAL FACTOR

摘要

The inventors discovered that by administering a pharmaceutical composition comprising a bispecific antigen-binding molecule that recognizes blood coagulation factor IX and/or activated blood coagulation factor IX and blood coagulation factor X and/or activated blood coagulation factor X according to a given dosage regimen, diseases that develop and/or progress due to a decrease or deficiency in the activity of blood coagulation factor VIII and/or activated blood coagulation factor VIII can be prevented and/or treated more effectively.